Vaborbactam
Back to searchMolecule Structure
Scientific Name
Vaborbactam
Description of the Drug
Vaborbactam is a beta lactamase inhibitor used to treat complicated urinary tract infections.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB12107
http://www.drugbank.ca/drugs/DB12107
Brand Name(s)
Not Available
Company Owner(s)
Rempex Pharmaceuticals Inc A Wholly Owned Sub Of Melinta Therapeutics Llc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Carbepenem-hydrolyzing beta-lactamase KPC | SINGLE PROTEIN | INHIBITOR | CHEMBL6132 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL620289 |
| DrugBank | DB12107 |
| PubChem: Thomson Pharma | 134427008 |
| PubChem | 56649692 |
| Nikkaji | J3.437.623I |
| PDBe | 4D6 |
| BindingDB | 50089084 |
| DrugCentral | 5253 |
| Brenda | 206587 |
| ChemicalBook | CB53165815 |
| Guide to Pharmacology | 10871 |
| rxnorm | VABORBACTAM |
